Doctor profile · Federal record

Dr. Tia Janicki, PA-C

Physician Assistant · Physician Assistant · Fairhope, AL

  • NPI 1972636843
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 22 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
7550 Assunta CT
Fairhope, AL 365323069
(251) 928-4944
fax (251) 928-2086
Additional location
1300 N McKenzie St
Foley, AL 365352232

Credentials & registration

NPPES · NUCC
NPI registered
March 2007 — 19 yrs on file
Profile last updated
April 10, 2026
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
363A00000X — NUCC code
State licenses (2)
Alabama #PA.1780 · Florida #PA9118346

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1972636843. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
14,100
Distinct HCPCS
10
Medicare allowed
$176,812
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 10,800 42 $2
17003 Destruction of precancer skin growth, 2-14 growths 841 157 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 573 386 $70
11102 Biopsy of related skin growth, first growth 278 242 $66
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 263 41 $1
17000 Destruction of precancer skin growth, 1 growth 261 206 $35
99214 Established patient office or other outpatient visit, 30-39 minutes 234 141 $100
17110 Destruction of skin growth, 1-14 growths 159 140 $79
11103 Biopsy of related skin growth, each additional growth 145 91 $39
99203 New patient office or other outpatient visit, 30-44 minutes 88 88 $87

In context: peer comparison

Among 6 peers in this city , average services per provider: 341. This provider delivers 41× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,238
Transactions
98
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 14 $384.47
UCB, Inc. 7 $289.43
ABBVIE INC. 16 $269.62
Incyte Corporation 7 $209.36
Regeneron Healthcare Solutions, Inc. 9 $175.62
Dermavant Sciences, Inc. 11 $143.96
PFIZER INC. 10 $140.79
SUN PHARMACEUTICAL INDUSTRIES INC. 5 $138.43
Janssen Biotech, Inc. 4 $98.37
E.R. Squibb & Sons, L.L.C. 4 $82.85
Lilly USA, LLC 3 $63.95
GENZYME CORPORATION 3 $56.81
Amgen Inc. 2 $54.05
Arcutis Biotherapeutics, Inc. 2 $35.50
Verrica Pharmaceuticals Inc. 1 $21.58

By nature of payment

Food and Beverage
$2,103
Education
$135

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,142
Patients
582
Total drug cost
$30,615
Drug Type Claims Patients Total cost
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 131 49 $2,883
Clobetasol Propionate Generic 112 66 $5,775
Triamcinolone Acetonide Generic 111 74 $1,945
Minocycline Hcl Generic 102 67 $3,203
Fluconazole Generic 100 49 $1,304
Betamethasone Dipropionate Generic 97 44 $3,568
Pentoxifylline Generic 95 32 $4,430
Ammonium Lactate Generic 69 39 $1,789
Hydrocortisone Generic 56 41 $507
Ketoconazole Generic 52 35 $1,315

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Tia Janicki's medical specialty?
Dr. Tia Janicki practices Physician Assistant in Fairhope, AL.
Where does Dr. Tia Janicki practice?
Dr. Tia Janicki practices at 7550 Assunta CT, Fairhope, AL 365323069. Office phone: 2519284944.
What is Dr. Tia Janicki's NPI?
Dr. Tia Janicki's National Provider Identifier (NPI) is 1972636843, issued by NPPES.
Does Dr. Tia Janicki accept Medicare assignment?
Yes. Dr. Tia Janicki accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tia Janicki commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.